Pfizer/BioNTech says three doses ‘effective’ against Omicron

Funmilayo Ayanwusi
0 Min Read

Agency Report

The coronavirus vaccine developed jointly by BioNTech and Pfizer is “still effective” against the Omicron variant of the virus after three doses, the German company said in a statement on Wednesday.

An Omicron-specific version of the jab, currently in development by BioNTech, would be available “by March,” it added.

AFP

Share This Article